Results 51 to 60 of about 593,899 (165)

Cost-effectiveness of universal genetic screening for familial hypercholesterolemia in young adults aged 18–40 years in China

BMC Medicine
Background Mortality from familial hypercholesterolemia (FH) remains high due to late diagnosis, and the rate of timely diagnosis remains low (
Rui Meng, Fenghao Shi, Baoming Zhang, Chao Li, Jinyan Wang, Lingqin Song, Lei Zhang, Mingwang Shen   +7 more
doaj   +1 more source

Cost-effectiveness of screening for amblyopia among kindergarten children in China

Preventive Medicine Reports
Objective: Current cost-effectiveness analyses of amblyopia screening are mainly from western countries. It remains unclear whether it is cost-effective to implement a preschool amblyopia screening programme in China. Our study aimed to evaluate the cost-
Yu-Ting Gu, Bing Shi, Dan-Lin Li, Tian-Tian Zhang, Pei Wang, Jie Jiang, Chen-Wei Pan   +6 more
doaj   +1 more source

The cost of oral screening

British Dental Journal, 1991
Ogden, G. R., Cowpe, J. G., Chisholm, D. M.   +2 more
openaire   +3 more sources

Cost-Effective Screening for Trichomoniasis

Emerging Infectious Diseases, 2002
Jane R. Schwebke
doaj   +1 more source

National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling

BMJ Open
Objective The aim of this study was to estimate the total national direct cost of breast cancer screening from 2019 to 2022 and project the total national cost and average lifetime cost of screening per woman for three current guidelines.Design We ...
Martin Eklund, Kimberly Badal, James Staib, Jeffrey A. Tice, Mi-Ok Kim, Leslie Wilson, Stacey Dacosta Byfield, Kierstin Catlett, Liz Maffey, Rashna Soonavala, Yiwey Shieh, Laura J. Esserman   +11 more
doaj   +1 more source

Health economics evaluation of screening for sarcopenia among community-dwelling older persons

BMC Public Health
Objective Sarcopenia increased the risk of various adverse outcomes, including cardiovascular diseases, falls, and mortality. Implementing interventions could mitigate the harm caused by sarcopenia.
Yang Liu, Boran Sun, Jingyue Wang, Zhanliang Ruan, Yuan Wang, Jian Sun, Shu Wang, Wenli Lu   +7 more
doaj   +1 more source

Costs of screening programmes. [PDF]

BMJ, 1970
R, Hurley, A P, Norman
openaire   +2 more sources

The Screening Cost of Liquidity

A principal with cheap capital optimally forces her counterparty to borrow at above-market rates. The reason: the form of finance is a screening device. Advances provide liquidity but pool types; contingent transfers separate types, but, because they are not pledgeable, impose financing costs.
openaire   +2 more sources

The impact of adherence on colorectal cancer screening cost-effectiveness: A modeling study. [PDF]

PLoS Med
Xie J, Dong X, Luo Z, Wang C, Zheng Y, Chen X, Guo Z, Shi X, Wang F, Cao W, Xu Y, Wang L, Wu W, Hang D, Du L, Li N.   +15 more
europepmc   +1 more source

Is universal depression screening cost-effective across all Indian states? Addressing parameter uncertainty. [PDF]

Lancet Reg Health Southeast Asia
Niu Z, Tang W, Zhang J.
europepmc   +1 more source